Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease (Q24235161)

object named as

Kristin V Carson

0 references

author name string

Zafar A Usmani

0 references

Jien N Cheng

0 references

Adrian J Esterman

0 references

Brian J Smith

Cochrane Database of Systematic Reviews

0 references

publication date

9 November 2011

0 references

published in

0 references

cites work

Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Psychophysical bases of perceived exertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Influence of anxiety on health outcomes in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Functional impairment in COPD patients: the impact of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Anxiety and depression in COPD: current understanding, unanswered questions, and research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Citalopram and quality of life in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

An explanatory model of functional status in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Management of anxiety and depression in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

7 January 2021

The St George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

7 January 2021

Two-, six-, and 12-minute walking tests in respiratory disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

7 January 2021

Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008483.PUB2

7 January 2021